An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...
New York City council data scientist says organisations should get their hands dirty with open source AI as his teams build ...
To sweeten the incentive, the celebrity video greetings site is also providing a daily catered lunch, a gym membership and ...
Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma ...
One Maidu and Wintun woman discovered what happens when floating tule on water. The growth of life might be able to limit ...
The new strain of the virus (pictured) first arrived in England in November 2023 but has quickly spread, with the so-called ...
Q4 2024 Earnings Conference Call February 14, 2025 3:00 AM ETCompany ParticipantsMasamichi Terabatake - Group President ...
In his magisterial two-volume Political Order books, Francis Fukuyama writes extensively about patronage networks, ...
Researchers at Imperial College London are leading human trials for the innovative treatmentAn inhalable medicine with the potential to improve lung ...
Uganda’s malaria burden is staggering, with some areas such as Apac District recording the world’s highest density of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results